Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease.

Mohajeri, Sahar; Moayedi, Saeed; Mohajeri, Shabnam; Yadegar, Abbas; Haririan, Ismaeil

Mohajeri, Sahar; Moayedi, Saeed; Mohajeri, Shabnam; Yadegar, Abbas; Haririan, Ismaeil.

Afiliación

Mohajeri S; Department of Pharmaceutical Biomaterials, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Moayedi S; Department of Pharmaceutical Biomaterials, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Mohajeri S; Faculty of Food Science and Technology, Gorgan University of Agricultural Sciences and Natural Resources, Gorgan, Iran.
Yadegar A; Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Haririan I; Department of Pharmaceutical Biomaterials, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Front Pharmacol ; 13: 1045575, 2022.

Article en En | MEDLINE | ID: mdl-36438794

Palabras clave

biomaterials; colon; drug delivery systems; inflammatory bowel disease; pathophysiological changes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google